TASSO, MARCO
 Distribuzione geografica
Continente #
AS - Asia 1.313
NA - Nord America 811
EU - Europa 791
SA - Sud America 190
AF - Africa 27
Totale 3.132
Nazione #
US - Stati Uniti d'America 780
SG - Singapore 704
RU - Federazione Russa 484
CN - Cina 321
BR - Brasile 157
IT - Italia 138
HK - Hong Kong 113
VN - Vietnam 88
DE - Germania 46
GB - Regno Unito 24
IN - India 22
KR - Corea 21
CA - Canada 15
IE - Irlanda 15
NL - Olanda 15
AR - Argentina 12
FI - Finlandia 12
ES - Italia 11
MX - Messico 11
PL - Polonia 9
BD - Bangladesh 8
CI - Costa d'Avorio 8
UA - Ucraina 7
FR - Francia 6
ID - Indonesia 6
PY - Paraguay 6
ZA - Sudafrica 6
EC - Ecuador 5
JP - Giappone 5
SE - Svezia 5
AT - Austria 4
CZ - Repubblica Ceca 4
IQ - Iraq 4
TR - Turchia 4
CO - Colombia 3
GR - Grecia 3
LT - Lituania 3
PE - Perù 3
TN - Tunisia 3
UZ - Uzbekistan 3
VE - Venezuela 3
HR - Croazia 2
IL - Israele 2
LB - Libano 2
MA - Marocco 2
PK - Pakistan 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BE - Belgio 1
BS - Bahamas 1
CG - Congo 1
DZ - Algeria 1
GA - Gabon 1
GH - Ghana 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
KE - Kenya 1
LV - Lettonia 1
MY - Malesia 1
NA - Namibia 1
NP - Nepal 1
OM - Oman 1
SI - Slovenia 1
SV - El Salvador 1
TL - Timor Orientale 1
UY - Uruguay 1
Totale 3.132
Città #
Singapore 346
Ashburn 136
Moscow 136
Hong Kong 111
Hefei 106
Chandler 73
Beijing 72
Santa Clara 69
Ho Chi Minh City 38
Naples 24
Redondo Beach 22
Boston 21
Los Angeles 21
Millbury 21
Seoul 21
The Dalles 19
Hanoi 18
Lawrence 17
Munich 15
Buffalo 13
Cava de' Tirreni 13
São Paulo 13
New York 12
Dallas 11
Milan 11
Nanjing 11
Amsterdam 10
Des Moines 10
Hangzhou 9
Wilmington 9
Rome 8
Princeton 7
Seattle 7
Washington 7
Guangzhou 6
Asunción 5
Boardman 5
Brasília 5
Chennai 5
Chicago 5
Hải Dương 5
Napoli 5
Ottawa 5
Tokyo 5
Warsaw 5
Brno 4
Brooklyn 4
Denver 4
Dublin 4
Frankfurt am Main 4
Helsinki 4
London 4
Montreal 4
Mumbai 4
Mérida 4
Nanchang 4
Orem 4
Poplar 4
Shenyang 4
Sumaré 4
Ankara 3
Barcelona 3
Biên Hòa 3
Campoli del Monte Taburno 3
Cassano d'Adda 3
Fairfield 3
Guarulhos 3
Lima 3
Manchester 3
Mexico City 3
Nola 3
Phoenix 3
Redwood City 3
San Vicent del Raspeig 3
Springfield 3
Toronto 3
Turku 3
Vũng Tàu 3
Woodbridge 3
Wroclaw 3
Belém 2
Bengaluru 2
Bogotá 2
Canela 2
Charlotte 2
Chengdu 2
Contagem 2
Elk Grove Village 2
Falkenstein 2
Formello 2
Fuzhou 2
Ha Long 2
Haiphong 2
Hebei 2
Houston 2
Hyderabad 2
Jaboatão dos Guararapes 2
Jakarta 2
Jiaxing 2
Johannesburg 2
Totale 1.653
Nome #
Cardiovascular risk markers in patients with psoriatic arthritis: A meta-analysis of literature studies 148
Clinical assessment of endothelial function in patients with rheumatoid arthritis: A meta-analysis of literature studies 137
Analysis of rheumatoid- vs psoriatic arthritis synovial fluid reveals differential macrophage (CCR2) and T helper subsets (STAT3/4 and FOXP3) activation 136
Is there any association between psoriasis, psoriatic arthritis and thyroid autoimmunity? 108
Small molecule therapy for managing moderate to severe psoriatic arthritis 106
Non-invasive assessment of arterial stiffness in patients with rheumatoid arthritis: A systematic review and meta-analysis of literature studies 105
Subclinical atherosclerosis in patients with rheumatoid arthritis: A meta-analysis of literature studies 103
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study 97
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients 94
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 93
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy 92
Predominant ultrasonographic extracapsular changes in symptomatic psoriatic dactylitis: results from a multicenter cross-sectional study comparing symptomatic and asymptomatic hand dactylitis 92
Association between Leeds Dactylitis Index and ultrasonographic features: a multicentre study on psoriatic hand dactylitis 92
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis” 89
Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort 89
Improving telemedicine and in-person management of rheumatic and autoimmune diseases,during and after COVID-19 pandemic outbreak. Definite need for more Rheumatologists. Response to: 'Can telerheumatology improve rheumatic and musculoskeletal disease service delivery in sub-Saharan Africa?' by Akpabio et al 87
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 86
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 83
JAK Inhibitors in Psoriatic Disease 79
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 77
Recent developments for new investigational JAK inhibitors in psoriatic arthritis 75
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 72
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 72
Late-Onset and Elderly Psoriatic Arthritis: Clinical Aspects and Management 71
COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic's third wave 69
Coeliac disease is a risk factor for the development of seronegative arthritis in patients with autoimmune thyroid disease 65
Role of Patrick-FABER test in detecting sacroiliitis and diagnosing spondyloarthritis in subjects with low back pain 65
Ultrasound Effectiveness of Steroid Injection for hand Psoriatic Dactylitis: Results from a Longitudinal Observational Study 62
The negative impact of pain catastrophising on disease activity: analyses of data derived from patient-reported outcomes in psoriatic arthritis and axial spondyloarthritis 61
Psoriatic dactylitis: from immunopathogenesis to anti-cytokine and targeted synthetic therapies 60
Experimental and investigational pharmacotherapy for psoriatic arthritis: Drugs of the future 59
The Patrick-FABER test in detecting active sacroiliitis in spondyloarthritis patients: a prospective study using magnetic resonance as reference standard 58
Ultrasonographic Evidence of Predominance of Acute Extracapsular and Chronic Intrasynovial Patterns in 100 Cases of Psoriatic Hand Dactylitis 55
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 53
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 52
Rheumatologist’s Perspective on Non-Infectious Uveitis: Patterns from Tertiary Referral Rheumatologic Clinics in Italy 51
Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders 49
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement 46
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 41
Micronutrients deficiencies in patients with spondylarthritis: the potential immunometabolic crosstalk in disease phenotype 36
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 33
Assessing cardiovascular risk in rheumatoid arthritis patients on Janus kinase inhibitors: real-world data from the European Alliance of Associations for Rheumatology-adapted CUORE risk algorithm 15
Totale 3.213
Categoria #
all - tutte 10.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.416


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20219 0 0 0 0 0 5 0 1 3 0 0 0
2021/2022116 0 3 0 0 1 2 1 8 13 14 24 50
2022/2023202 25 8 4 21 27 23 3 19 39 12 14 7
2023/2024205 6 19 10 11 15 51 7 41 2 3 21 19
2024/20251.188 100 73 17 27 16 78 149 76 48 97 425 82
2025/20261.365 235 221 251 216 333 109 0 0 0 0 0 0
Totale 3.213